1. Regeneron starting late stage trials of coronavirus drug cocktail — Bristol-Myers pays Dragonfly Therapeutics $55M to bring NK cells to neuro diseases — JNJ in $480M-plus deal with Emergent for coronavirus vaccine supply — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Passing of Taro Iwamoto

Discussion in 'Otsuka' started by Anonymous, Feb 11, 2015 at 11:06 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Shell shock! What next for the company?
     

  2. Anonymous

    Anonymous Guest

    Why two days to announce? This seems like a big deal to delay such an announcement. Perhaps they wanted to have a successor announced before they did but out of respect, shouldn't they announce the passing of the highest leader? Make it more about his accomplishments, etc. and how he will be leaving a great legacy.
     
  3. Anonymous

    Anonymous Guest

    There is a report in Tokyo that Iwamoto-san was found at his house after not replying to calls/the door..apparently suspicious circumstances.
     
  4. Anonymous

    Anonymous Guest

    OMG?!!! Is this real? I just googled and there is nothing online.
    There have been rumors circulating in HO that he would soon be replaced!

    I hope this is somehow a mistake.
     
  5. Anonymous

    Anonymous Guest

    It's inappropriate and disrespectful for anyone to post rumors about the passing of Taro.
     
  6. Anonymous

    Anonymous Guest

    It's inappropriate and disrespectful for people to post rumors, period, but this is despicable.
     
  7. Anonymous

    Anonymous Guest

    Japan news reports he passed away of heart failure at the age of 54. Too young. Very sudden.
     
  8. Anonymous

    Anonymous Guest

    Killed OAPI long ago.
     
  9. Anonymous

    Anonymous Guest

    And does he get any credit for catapulting this company into a multibillion dollar organization? Shame on you hater!
     
  10. Anonymous

    Anonymous Guest

    He was a visionary leader who built this organization from the ground up. Without him, none of us would be here.

    All visionary leaders have intense talents and weaknesses.

    People should respect and honor all that he did for the company, your lives, and patient lives.

    Pease do not shame the US country , or employees with disrespectful behaviour.
     
    Mito Ko likes this.
  11. Anonymous

    Anonymous Guest

    It is very tragic that Taro has passed away reportedly from heart failure. The Japanese concept of Karoshi seems apt here; working oneself to the death. This should remind everyone here and over in Japan, of the importance of work-life balance.
     
  12. Anonymous

    Anonymous Guest

    Domo Arigato, Dr. Iwamoto
     
  13. Anonymous

    Anonymous Guest

    At least he wasn't traveling when he died. If he were traveling internationally that could have added an additional level of stress to his already grieving family. Since this was unexpected, they surely must be completely devastated. We should all keep his family in our thoughts during this time.
     
  14. Anonymous

    Anonymous Guest


    Too soon! but Holy crap was that funny
     
  15. Anonymous

    Anonymous Guest

    AMEN
     
  16. Anonymous

    Anonymous Guest

  17. Anonymous

    Anonymous Guest

  18. Anonymous

    Anonymous Guest

    Cold. Just a cold organization. Key member dies and business as usual.
     
  19. Anonymous

    Anonymous Guest

    Publicly traded companies are required to have a succession plan. They also are required to report quarterly (every 3/6/9/12 months). Nothing suspicious about that.
     
  20. Anonymous

    Anonymous Guest

    Otsuka is not listed on a U.S. exchange. And if you have anything else to say about it, please quantify your stock option grant total. 0.0